Sg3 Management, LLC Teva Pharmaceutical Industries LTD Transaction History

Sg3 Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $506,637 - $713,960	-68,650 Reduced 80.76%	16,350 $123,000
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $930,910 - $1.19 Million	-127,000 Reduced 59.91%	85,000 $798,000
Q4 2021 Feb 15, 2022	BUY	$7.9 - $10.19 $410,800 - $529,880	52,000 Added 32.5%	212,000 $1.7 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $297,000 - $346,800	-30,000 Reduced 15.79%	160,000 $1.58 Million
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $410,498 - $508,557	39,700 Added 26.41%	190,000 $2.19 Million
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $605,283 - $776,111	70,300 Added 87.88%	150,300 $1.45 Million
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $171,400 - $253,800	-20,000 Reduced 20.0%	80,000 $721,000
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $811,999 - $1.31 Million	100,000 New	100,000 $1.23 Million
Q2 2019 Aug 09, 2019	SELL	$8.12 - $15.72 $81,199 - $157,200	-10,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$14.59 - $23.84 $145,900 - $238,400	10,000 New	10,000 $154,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.